News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Vir Biotechnology rallied after a Phase-3 trial win, pushing market capitalization to about $2.34 billion.
  • Valuation appears tight versus near-term binary catalysts; cautious long recommended with limited position size and a hard stop.
  • Celestica trades near $223 after a steep fall from its 52-week peak while reporting $545 million in free cash flow.
  • Recommend a tactical 45-day short on Celestica driven by sagging AI revenue expectations.
  • Event-driven stock trades dominated the hour, with catalyst-driven biotech moves and targeted shorts in AI-supply names.

Latest Articles

Yen Strengthens as Markets Push Back BOJ Timing and Price in a September Hike

Yen Strengthens as Markets Push Back BOJ Timing and Price in a September Hike

The Japanese yen extended its recent advance on Tuesday, hitting a seven-month high against the dollar as traders intensified expectations that the Bank of Japan will raise interest rates at its Sept. 17-18 policy meeting. Upward revisions to second-quarter GDP and a notable rise in real wages added momentum to the currency's move, while Tokyo reit…

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

Nyxoah has announced the first patient implantation in BREATHE, a U.S. post-approval study designed to evaluate the long-term safety and effectiveness of its Genio® system in treating moderate to severe obstructive sleep apnea (OSA). The multicenter study will enroll up to 229 patients across 25 U.S. centers and follow them for up to five years to …

Haitian Gangs Move Tactics to Countryside, Report Finds

Haitian Gangs Move Tactics to Countryside, Report Finds

A report from the Global Initiative Against Transnational Organized Crime’s Haiti Observatory finds that armed gangs are increasingly operating beyond Port-au-Prince, employing small, mobile units to conduct rapid raids, kidnappings, cattle theft and roadblocks in rural areas. The shift is affecting agricultural zones and transportation corridors a…

Banking Rollout + Rising Merchant GPV: A Tactical Long on Block (SQ)

Banking Rollout + Rising Merchant GPV: A Tactical Long on Block (SQ)

Block's payments stack is showing evidence of two parallel growth engines: merchant GPV expanding at the point-of-sale and banking actives building a recurring-deposit base. That mix can improve both top-line visibility and margin profile over time. This trade idea lays out an actionable long with precise entry, stop and target, timeframe, catalyst…

Curtiss-Wright: Buy the Dip in America's Defense Modernizer

Curtiss-Wright: Buy the Dip in America's Defense Modernizer

Curtiss-Wright (CW) is a diversified supplier to aerospace, naval and defense programs that just sold off despite beating earnings and raising guidance. Strong free cash flow ($625M TTM), expanding margins and direct exposure to U.S. defense modernization make CW a compelling long-term trade after a pullback. Valuation is not cheap, but the risk/re…

Intapp Breakout: Why This Rebound Has Room to Run

Intapp Breakout: Why This Rebound Has Room to Run

Intapp (INTA) has retraced aggressively from its May low and is showing constructive technicals and improving business signals. With a $3.19B market cap, positive free cash flow, and product recognition in private credit and deal origination, the risk/reward favors a mid-term long trade. Entry, stop and target levels below reflect both fundamental …

Scholar Rock: Buy the Manufacturing Dip, Play the Muscle-Targeted Upside

Scholar Rock: Buy the Manufacturing Dip, Play the Muscle-Targeted Upside

Catalent-related manufacturing noise has knocked Scholar Rock (SRRK) off its earlier momentum. The core commercial thesis - apitegromab as a muscle-targeted adjunct in spinal muscular atrophy (SMA) - still stands. This trade idea buys into that fundamental upside while limiting downside with a defined stop and a clear time box tied to regulatory an…

Why AMD Looks Overpriced vs. the AI Chip Crowd - A Tactical Short Idea

Why AMD Looks Overpriced vs. the AI Chip Crowd - A Tactical Short Idea

Advanced Micro Devices (AMD) trades at $477.45 with a market capitalization near $779B and valuation multiples that imply perfect execution on an aggressive AI-data-center ramp. That optimism is priced in: P/E ~122, EV/EBITDA ~92 and EV roughly equal to market cap. This trade idea proposes a mid-term short against a pullback to more realistic multi…

Evolv at a 52-Week Low: A High-Reward Rebound Trade

Evolv at a 52-Week Low: A High-Reward Rebound Trade

Evolv Technologies (EVLV) is trading at roughly $5.00, close to its 52-week low. The business continues to grow revenue and expand deployments across education, entertainment and commercial customers, and management has recently lifted sales guidance. That combination plus a relatively small short base creates a defined asymmetric trade: a long pos…

Broadcom: Market Is Skeptical — Time to Add a Tactical Long

Broadcom: Market Is Skeptical — Time to Add a Tactical Long

Broadcom just reported blowout AI semiconductor growth but the stock is trading well below its 52-week high amid cautious guidance. Fundamentals — including $32.8B in free cash flow, a $1.7T market cap, and AI revenue momentum — support a tactical long in the mid term (45 trading days). This trade idea provides an entry, stop, and target while outl…

Nvidia: Building an AI Ecosystem — Trade Idea for a Mid-Term Swing

Nvidia: Building an AI Ecosystem — Trade Idea for a Mid-Term Swing

Nvidia has moved beyond being a chipmaker to assembling an integrated AI stack of hardware, networking, and software. The market is pricing growth, but fundamentals - strong free cash flow, high ROE, and improving technicals - support another leg higher. This is a mid-term swing trade to capture momentum as the company integrates Hugging Face and e…